Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center

Zhou M, Min Zhou, Jinyun Chen, Chen JY, Jin-Yun Chen, Liangdan Tang, Liang-Dan Tang, Tang LD, Chen WZ, Wen-Zhi Chen, Wenzhi Chen, Zhi-Biao Wang, Zhibiao Wang, Wang ZB
Fertility and sterility · 2010 · vol. 95(3) , pp. 900–905 · doi:10.1016/j.fertnstert.2010.10.020 · PMID:21067723 · W2073145938
Non-randomised trial OA: closed CC0 ⤵ 70 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

This paper reports on the clinical experience of a single center utilizing ultrasound-guided high-intensity focused ultrasound ablation for treating adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To assess the midterm outcomes after ultrasound-guided high-intensity focused ultrasound (HIFU) ablation in treatment of patients with symptomatic adenomyosis. DESIGN: A prospective clinical trial. SETTING: University teaching hospital. PATIENT(S): Seventy-eight patients with symptomatic adenomyosis. INTERVENTION(S): A single treatment session of ultrasound-guided HIFU ablation for adenomyosis. MAIN OUTCOME MEASURE(S): Dysmenorrhea and menorrhagia scores and the incidence of complications. RESULT(S): In all 78 patients, 84.6% tolerated the treatment procedure well with pain scores between 0 and 4. Treatment was terminated in only one patient because of increased blood pressure persistently. Sixty-nine patients have finished at least an 18-month follow-up; the mean follow-up time was 24.2 months. Nonperfused regions in lesions were observed in 60 (87.0%) patients on the enhanced magnetic resonance imaging scans. Scores for menorrhea and dysmenorrhea decreased. Clinical effectiveness of the treatment was observed in 62 women (89.9%) with varying degrees of symptomatic relief of dysmenorrhea. Eight patients had relapses. Twenty-two patients (28.6%) had 27 complications. Of these, four had two or more complications. Twenty-three events (85.1%) did not need medical intervention (Society of Interventional Radiology class A). No serious complications including death or major permanent injuries were observed. CONCLUSION(S): Ultrasound-guided HIFU ablation may be a safe and effective noninvasive alternative in the treatment of symptomatic adenomyosis.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosis

MeSH descriptors

Endometriosis Endometriosis High-Intensity Focused Ultrasound Ablation Adult Adult Endometriosis Endometriosis Endometriosis Female Female Follow-Up Studies Follow-Up Studies High-Intensity Focused Ultrasound Ablation High-Intensity Focused Ultrasound Ablation High-Intensity Focused Ultrasound Ablation Humans Humans Magnetic Resonance Imaging Magnetic Resonance Imaging Middle Aged

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (30)

Cited by (50)

Source provenance

europepmc
last seen: 2026-10-13T06:10:10.580696+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:08:15.389298+00:00
License: CC0 · commercial use OK